New Medication Breakthrough: How Researchers Are Protecting Diabetics from Heart Attacks
Medical researchers are increasingly shifting the focus of diabetes management from simple blood glucose control to the prevention of cardiovascular complications, which remain the leading cause of mortality for patients with Type 2 diabetes. New pharmacological classes, particularly GLP-1 receptor agonists and SGLT2 inhibitors, have demonstrated significant efficacy in reducing the risk of heart attacks, … Read more